You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 151 No. 10, OCTOBER 1991 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  REVIEW ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (120)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Atherogenic Effects of Anabolic Steroids on Serum Lipid Levels

A Literature Review

Gary Glazer, MD

Arch Intern Med. 1991;151(10):1925-1933.


Abstract



This article reviews the current body of literature linking anabolic steroids to atherogenic alterations in serum lipid levels. Anabolic steroids cause marked high-density lipoprotein level depression (weighted average, 52%) and severe depression of high-density lipoproteinb levels (weighted average, 78%) while raising low-density lipoprotein levels an average of 36%. The mechanism of these lipid changes, their time course in relation to anabolic steroid use, and their dependency on route of anabolic steroid administration are discussed. Interpretation of the observed lipid level changes in light of the epidemiologic data linking lipids to coronary heart disease risk is used to estimate the lipid-based increase in coronary heart disease risk due to anabolic steroid use.

(Arch Intern Med. 1991;151:1925-1933)



Author Affiliations



From Highland Hospital, Rochester, NY.


Footnotes



Accepted for publication March 29, 1991.

Reprint requests to Highland Hospital, 1000 South Ave, Rochester, NY 14620 (Dr Glazer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Androgen Abuse in Athletes: Detection and Consequences
Basaria
J. Clin. Endocrinol. Metab. 2010;95:1533-1543.
ABSTRACT | FULL TEXT  

Acute Myocardial Infarction in a Young Man Using Anabolic Steroids
Wysoczanski et al.
ANGIOLOGY 2008;59:376-378.
ABSTRACT  

ESC Study Group of Sports Cardiology Position Paper on adverse cardiovascular effects of doping in athletes
Deligiannis et al.
European Journal of Cardiovascular Prevention & Rehabilitation 2006;13:687-694.
ABSTRACT | FULL TEXT  

Homocysteine induced cardiovascular events: a consequence of long term anabolic-androgenic steroid (AAS) abuse
Graham et al.
Br. J. Sports. Med. 2006;40:644-648.
ABSTRACT | FULL TEXT  

Popular Ergogenic Drugs and Supplements in Young Athletes
Calfee and Fadale
Pediatrics 2006;117:e577-e589.
ABSTRACT | FULL TEXT  

Effects of Androgen Therapy on Adipose Tissue and Metabolism in Older Men
Schroeder et al.
J. Clin. Endocrinol. Metab. 2004;89:4863-4872.
ABSTRACT | FULL TEXT  

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a)
Hartgens et al.
Br. J. Sports. Med. 2004;38:253-259.
ABSTRACT | FULL TEXT  

Androgen therapy improves muscle mass and strength but not muscle quality: results from two studies
Schroeder et al.
Am. J. Physiol. Endocrinol. Metab. 2003;285:E16-E24.
ABSTRACT | FULL TEXT  

Metabolic effects of nandrolone decanoate and resistance training in men with HIV
Sattler et al.
Am. J. Physiol. Endocrinol. Metab. 2002;283:E1214-E1222.
ABSTRACT | FULL TEXT  

Testosterone and Cardiovascular Risk Factors
Cohen et al.
Arch Intern Med 2000;160:2064-2065.
FULL TEXT  

Male Pattern Baldness and Coronary Heart Disease: The Physicians' Health Study
Lotufo et al.
Arch Intern Med 2000;160:165-171.
ABSTRACT | FULL TEXT  

Testosterone, Sex Hormone-Binding Globulin, Lipoproteins, and Vascular Disease Risk
Dickerman et al.
European Journal of Cardiovascular Prevention & Rehabilitation 1997;4:363-366.
ABSTRACT  

Effects of a Multidimensional Anabolic Steroid Prevention Intervention: The Adolescents Training and Learning to Avoid Steroids (ATLAS) Program
Goldberg et al.
JAMA 1996;276:1555-1562.
ABSTRACT  

Testosterone and Thromboxane : Of Muscles, Mice, and Men
Pratico and FitzGerald
Circulation 1995;91:2694-2698.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.